NCT06974110
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06974110
Title Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors MOMA Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS